Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 416
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | ||
| NCT00245154 | Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00004251 | Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer | ||
| NCT00002583 | Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed | ||
| NCT05255653 | Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features | ||
| NCT03127631 | A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients | ||
| NCT02414022 | Economic Analysis of Alliance A041202 CLL Study | ||
| NCT00005974 | Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma | ||
| NCT00075660 | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma | ||
| NCT02308085 | Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer | ||
| NCT03285841 | OCT-AF Imaging of Pre-cancers of Vulva and Cervix | ||
| NCT02905318 | Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer | ||
| NCT01419886 | Testing of a New Scale Measuring Medical Outcomes of Dysphagia (MOD) in Adult Patients With Swallowing Disorders | ||
| NCT00258388 | Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy | ||
| NCT02620735 | Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:Protocol | ||
| NCT03488693 | Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer | ||
| NCT00514085 | Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma | ||
| NCT01101438 | A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer | ||
| NCT01267097 | The PAC Study: Parents as Agents of Change in Pediatric Weight Management | ||
| NCT00003891 | Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors | ||
| NCT03822897 | De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma | ||
| NCT00003140 | Letrozole After Tamoxifen in Treating Women With Breast Cancer | ||
| NCT01089933 | Reducing Pain and Disability After Breast Cancer Surgery | ||
| NCT05300711 | Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery | ||
| NCT00471432 | OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | ||
| NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | ||
| NCT01331083 | A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer | ||
| NCT00003686 | Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids | ||
| NCT02788773 | Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer | ||
| NCT06781762 | Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer | ||
| NCT05714891 | Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer | ||
| NCT01907880 | The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer | ||
| NCT05998642 | Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma | ||
| NCT00010179 | Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer | ||
| NCT00066586 | Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer | ||
| NCT01847976 | Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer | ||
| NCT01141933 | Creating Meaning Following Cancer: An Intervention to Improve Existential and Global Quality of Life | ||
| NCT03795493 | Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer | ||
| NCT03410615 | Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC | ||
| NCT00516828 | Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | ||
| NCT01075308 | SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer | ||
| NCT01237639 | Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation | ||
| NCT07297667 | GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours | ||
| NCT02501031 | Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women | ||
| NCT00148057 | Diet and Breast Cancer Prevention Trial | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT01542177 | A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer | ||
| NCT03847649 | A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies | ||
| NCT01982786 | Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer | ||
| NCT00040183 | OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. |
